Dechra Veterinary Products has launched Myorelax, a guaifenesin 100 mg/ml solution indicated for the induction of muscle relaxation and immobilisation, as an adjunct to balanced anaesthesia.
Dechra Veterinary Products has launched the latest addition to its equine anaesthesia range to the UK.
Myorelax, a guaifenesin 100 mg/ml solution, is indicated for the induction of muscle relaxation and immobilisation, as an adjunct to balanced anaesthesia.
It can be combined with a number of sedatives and anaesthetics including detomidine, ketamine and propofol plus local and volatile anaesthetics.
Dechra’s equine brand manager Emma Jennings said: “Myorelax is a centrally acting muscle relaxant which is effective within a few minutes and does not affect the animal’s respiratory muscles at therapeutic doses. It can be used in combination with a sedative and local anaesthetics for short procedures and together with appropriate general anaesthetics for induction and maintenance of muscle relaxation during anaesthesia.”
Horses are able to stand within 45 minutes after single administration, and the product can be used in a “triple drip” protocol for total intravenous anaesthesia.
Myorelax is available in 500ml bottles and available from veterinary wholesalers now.
- For further information, visit www.dechra.co.uk